Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -6.90% vs 12.45% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -41.70% vs 527.40% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -25.49% vs 82.88% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 11.86% vs -34.44% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of HPGC Renmintongtai Pharmaceutical Corp. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -6.90% vs 12.45% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.04% vs -9.02% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -41.70% vs 527.40% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -53.08% vs -30.01% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -25.49% vs 82.88% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -26.31% vs -35.76% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 11.86% vs -34.44% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -8.33% vs 9.09% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






